FDA Breakthrough designation supports development of a point-of-care test for detecting folate receptor autoantibodies ...
NEW YORK, NY, UNITED STATES, January 12, 2026 /EINPresswire.com/ — Micoy Therapeutics today announced that the NeuroLume™ Test has been granted Breakthrough ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results